Home -> Law Blog Directory -> Personal Injury Law Blogs -> Boston Injury Lawyer Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Boston Injury Lawyer BlogMassachusetts Dangerous Drug Lawsuit Says Raptiva Caused Serious Infections
By Altman & Altman
Gerald Sylvia is suing Xoma LLC and Genentech, Inc. for Massachusetts personal injury. In his dangerous drug lawsuit, he claims that the drug Raptiva caused him to develop acute retinal necrosis and meningitis. He is now legally blind.
Genentech recalled Raptiva in 2009 after the drug, used to treat psoriasis, was linked to three suspected cases of progressive multifocal leukoencephalopathy (PML), a deadly brain infection that can turn fatal. In addition to attacking the central nervous system, PML can cause paralysis, speech impairment, vision loss, weakness, cognitive deterioration, and death.
Raptiva, a subcutaneous injection, increased the risks of life-threatening infections, lymphoma, neurological complications, malignancy, and death. Sylvia claims that the drug manufacturers knew about the health risks posed by the drug yet failed to warn physicians or patients. He says that the defendants allowed the defective drug to remain in the market when they knew there were safer options.
Unfortunately, each year, thousands of Americans are killed because of adverse side effects from taking prescription drugs and over-the-counter medications. In some cases, a defective drug is allowed to remain in the marketplace even after the medication has caused serious side effects in users. Failure to warn of possible side effects has resulted in health complications that could otherwise have been prevented.
It is a drug maker?s responsibility to make sure that their medications don?t cause catastrophic injuries or serious health issues. When a drug manufacturer fails in this duty, the victim or his/her family may have grounds for a Boston dangerous drug lawsuit.
Sylvia et al v. Genentech, Inc. et al, Justia Dockets & Filings
Raptiva is withdrawn from the US market, UPI.com, April 9, 2009
Related Web Resources:
Raptiva, National Institutes of Health
Other Dangerous Drug Blog Posts:
Boston Dangerous Drug: Taking Darvocet or Darvon Can Cause Heart Problems, Boston Injury Lawyer, January 28, 2011
Boston, Massachusetts Personal Injury: Are Dietary Supplements Dangerous Drugs?, Boston Injury Lawyer, August 4, 2010
Pfizer Settles for $400,000 the Massachusetts Dangerous Drug Lawsuit Filed by Family of Neurontin User who Committed Suicide, Boston Injury Lawyer, April 5, 2010
Full post as published by Boston Injury Lawyer Blog on February 08, 2011 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Copyright Lawsuits: Critical Issues Before Filing Copyright
Federa Rule 11(b) Considerations
Vioxx Lawsuits
Vioxx personal injury suits are a seroius concern for Merck and patietns
Construction Site Accidents
Lawsuits related to accidents
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Massachusetts Employment Law
alleging violations of Massachusetts labor laws including overtime pay, discrimination, harassment and more.
Raptiva
3 Patients Dead from Therapy-Related PML
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Massachusetts Turnpike Class Action
McKesson Corp.
$13.25 million settlement in lifestyle drug abuse lawsuit.
Drug Pusher
Biovail agrees to pay $24.6 million settlement in criminal lawsuit.

Psoriasis Drug Raptiva Alleged To Have Caused Hodgkin's Lymphoma Just Before April 2009 Recall
Raptiva PML Deaths Under FDA Review: Safety of Genentech's Psoriasis Drug Questioned
Raptiva Joins List of Drugs with Deadly Side Effects
FDA Announces Label Change For Raptiva
The Real Impact of FDA Raptiva Removal








